Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial.

@article{Sarin1996EfficacyOL,
  title={Efficacy of low-dose alpha interferon therapy in HBV-related chronic liver disease in Asian Indians: a randomized controlled trial.},
  author={Shiv Kumar Sarin and Rajkumar Chandra Guptan and Varsha Thakur and Sarla Malhotra and Veena Malhotra and Kaberi Banerjee and Pramod Khandekar},
  journal={Journal of hepatology},
  year={1996},
  volume={24 4},
  pages={391-6}
}
BACKGROUND/AIMS Interferon therapy has been shown to be effective in Western patients with chronic hepatitis due to hepatitis B viral infection, but not in Asian Chinese. Its efficacy in Asian Indian subjects with chronic HBV infection is not known. METHODS Forty-one patients with HBV-related chronic liver disease received randomly either: (a) recombinant alpha 2b interferon (n = 20) 3 MIU, subcutaneously, three times a week for 4 months, or (b) no treatment (n = 21). Patients were followed… CONTINUE READING